Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.820
-0.010 (-0.55%)
Mar 6, 2026, 12:51 PM EST - Market open
Chemomab Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 3.66 | 3.41 | 7.08 | 11.56 | 6.03 | 1.29 | |
| Research & Development | 7.15 | 11.33 | 18.38 | 16.98 | 6.33 | 4.68 | |
| Operating Expenses | 10.81 | 14.74 | 25.46 | 28.53 | 12.37 | 5.97 | |
| Operating Income | -10.81 | -14.74 | -25.46 | -28.53 | -12.37 | -5.97 | |
| Interest Expense | - | - | - | - | -0.11 | - | |
| Interest & Investment Income | 0.71 | 0.79 | 1.22 | 0.35 | - | 0.04 | |
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0.01 | - | - | -0.02 | |
| Pretax Income | -10.09 | -13.95 | -24.22 | -28.18 | -12.48 | -5.95 | |
| Income Tax Expense | - | - | - | -0.53 | - | - | |
| Net Income | -10.09 | -13.95 | -24.22 | -27.65 | -12.48 | -5.95 | |
| Net Income to Common | -10.09 | -13.95 | -24.22 | -27.65 | -12.48 | -5.95 | |
| Shares Outstanding (Basic) | 6 | 4 | 3 | 3 | 3 | 2 | |
| Shares Outstanding (Diluted) | 6 | 4 | 3 | 3 | 3 | 2 | |
| Shares Change (YoY) | 63.31% | 52.79% | 3.26% | 9.70% | 51.71% | - | |
| EPS (Basic) | -1.67 | -3.11 | -8.25 | -9.72 | -4.81 | -3.48 | |
| EPS (Diluted) | -1.67 | -3.11 | -8.25 | -9.72 | -4.81 | -3.48 | |
| Free Cash Flow | - | -15.39 | -23.61 | -20.44 | -12.61 | -5.28 | |
| Free Cash Flow Per Share | - | -3.43 | -8.04 | -7.18 | -4.86 | -3.09 | |
| EBITDA | -10.76 | -14.69 | -25.39 | -28.48 | -12.33 | -5.95 | |
| D&A For EBITDA | 0.04 | 0.05 | 0.07 | 0.06 | 0.03 | 0.02 | |
| EBIT | -10.81 | -14.74 | -25.46 | -28.53 | -12.37 | -5.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.